RedCarpetLife
Billionaires
Business
Luxury Lifestyle
Lists
World Leaders
Fashion & Style
Tools
Featured Articles
Learn Finance with Arthalogy
Advertise with RedCarpetLife
Contact Us
Careers at RedCarpetLife
Meet Our Authors
About Us
Correction or Feedback
Terms of Use
Privacy Policy
1454
In the world today
M. Satyanarayana Reddy

M. Satyanarayana Reddy

M. Reddy
-0.34% | - $-9.80M
$2.84 B ₹ 25,864 Cr
Real Time Net Worth #1454 Ranking as of 21 Feb 2026 By Forbes
Check Your Ranking

More on M. Satyanarayana Reddy

Gender

Male

Age

55Y

Country

India

Born On

August, 1970

Deceased

No

Relationship Status

Unknown

Children

2

Education

Osmania University - PhD

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Pharmaceuticals)

Primary Organization

MSN Group

Titles

Founder & Chairman

Sources of Wealth

Pharmaceuticals

Industry

Healthcare, Pharmaceuticals

About M. Satyanarayana Reddy

M . Satyanarayana Reddy is the founder and chairman of MSN Group, one of India's fastest-growing research-based pharmaceutical companies. A scientist with a PhD in organic chemistry, he established the Hyderabad-based group in 2003 with a focus on making affordable generic medicines. The company has since expanded to include 16 manufacturing facilities across India, the U.S., and Myanmar. During the COVID-19 pandemic, MSN Group gained recognition for launching a low-cost version of the antiviral drug Favipiravir.

Advertisement

Quick Reads

Early Life and Background

M. Satyanarayana Reddy is an Indian pharmaceutical tycoon, the founder and chairman of MSN group, headquartered in Hyderabad.

He founded the group in 2003 with a mission to make affordable generic drugs. Today, the private group consists of five privately held companies and has 16 factories across India, Myanmar and the U.S..

  • Core Company: MSN group (Affordable generic drugs).
  • Founding: Founded in 2003.
  • Scale: Has 16 factories across India, Myanmar and the U.S. and a team of over 14,000 qualified professionals.

Career Journey of M. Satyanarayana Reddy

M. Satyanarayana Reddy's career is defined by his commitment to providing affordable healthcare solutions. His structural achievement is building the MSN group into a fully integrated pharmaceutical company, focusing on the research, development, and manufacturing of high-quality, affordable generic drugs.

During the 2020 pandemic, MSN started making a low-priced version of the Covid-19 drug Favipiravir under the brand name Favilow. The group has achieved a global distinction for its innovation, quality and speed of delivery.

Advertisement

M. Satyanarayana Reddy's Timeline

2003:

Founded the MSN group.

2020:

Started making a low-priced version of the Covid-19 drug Favipiravir.

Ongoing:

Continues as Founder and Chairman, overseeing 16 factories globally.

Major Business Ventures and Investments

M. Satyanarayana Reddy's wealth is concentrated in his founding equity and continued leadership of the private pharmaceutical giant, MSN group.

  • MSN group (Founder & Chairman): Consists of five privately held companies that make affordable generic drugs.
  • Products: Portfolio includes 450+ APIs and 300+ Finished Dosages across 35 major therapeutic areas, including Oncology.
  • Pandemic Response: Manufactured a low-priced version of the Covid-19 drug Favipiravir.

Advertisement

Philanthropy and Social Impact

Fashion, Style, and Lifestyle

Advertisement

Quotes and Philosophy

No publicly available quotes.

Fun Facts & Trivia

  • He is the founder and chairman of MSN group, which was started in 2003 to make affordable generic drugs.
  • MSN has 16 factories across India, Myanmar and the U.S..
  • In 2020, MSN started making a low-priced version of the Covid-19 drug Favipiravir.
  • The group has over 14,000 qualified professionals.

Advertisement

More Profiles

Roman Abramovich & family

Roman Abramovich & family

#397

-3.08% | -$281.99M

Koo Bon-neung

Koo Bon-neung

#2878

+0.67% | +$8.11M

You May Like

Sources & References

This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content